# PROCARE - PROstate Cancer Real World Evidence Registry

> **NCT06835218** · — · RECRUITING · sponsor: **UroTrials Company (GmbH)** · enrollment: 5000 (estimated)

## Conditions studied

- Prostate Cancer
- Biochemical Recurrence of Malignant Neoplasm of Prostate
- Non-metastatic Castration-resistant Prostate Cancer
- Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- Metastatic Castration-resistant Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06835218
- **Lead sponsor:** UroTrials Company (GmbH)
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-29
- **Primary completion:** 2031-03-31
- **Final completion:** 2032-12-31
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06835218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06835218, "PROCARE - PROstate Cancer Real World Evidence Registry". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06835218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*